We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+8.88%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
–
AUM
$5B
AUM Growth
+$569M
Cap. Flow
+$92M
Cap. Flow %
1.84%
Top 10 Hldgs %
38.84%
Holding
3,762
New
250
Increased
1,451
Reduced
1,277
Closed
224

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$18.4M
2
ITOT icon
iShares Core S&P Total US Stock Market ETF
ITOT
+$9.77M
3
DYNF icon
BlackRock US Equity Factor Rotation ETF
DYNF
+$5.48M
4
MSFT icon
Microsoft
MSFT
+$4.93M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$4.9M

Top Sells

Rank Stock Value
1
CORT icon
Corcept Therapeutics
CORT
+$7.34M
2
SBUX icon
Starbucks
SBUX
+$4.7M
3
CMF icon
iShares California Muni Bond ETF
CMF
+$3.3M
4
RSP icon
Invesco S&P 500 Equal Weight ETF
RSP
+$2.63M
5
VB icon
Vanguard Morningstar Small-Cap ETF
VB
+$1.7M

Sector Composition

Rank Sector Weight
1 Technology 17.21%
2 Healthcare 9.68%
3 Financials 7.2%
4 Communication Services 5.16%
5 Consumer Discretionary 4.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EQC
3701
DELISTED
Equity Commonwealth
EQC
– –
-2,655
Closed -$4.28K
PDCO
3702
DELISTED
Patterson Companies, Inc.
PDCO
– –
-232
Closed -$7.26K
AMPS
3703
DELISTED
Altus Power
AMPS
– –
-2,428
Closed -$12K
PYCR
3704
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
– –
-2,374
Closed -$53.3K
ATSG
3705
DELISTED
Air Transport Services Group
ATSG
– –
-73
Closed -$1.64K
NVRO
3706
DELISTED
NEVRO CORP.
NVRO
– –
-456
Closed -$2.66K
ITCI
3707
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-1,982
Closed -$261K
TBNK
3708
DELISTED
Territorial Bancorp Inc.
TBNK
– –
-1,000
Closed -$8.38K
PTVE
3709
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
– –
-884
Closed -$15.9K
SASR
3710
DELISTED
Sandy Spring Bancorp Inc
SASR
– –
-764
Closed -$21.4K
FBMS
3711
DELISTED
The First Bancshares, Inc.
FBMS
– –
-51
Closed -$1.72K
CUTR
3712
DELISTED
Cutera, Inc.
CUTR
– –
-150
Closed -$2
NKLA
3713
DELISTED
Nikola Corporation Common Stock
NKLA
– –
-5
Closed -$1
VIRX
3714
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
– –
-8
Closed –
ASAI
3715
DELISTED
Sendas Distribuidora S.A. American Depositary Share (each representing five common shares)
ASAI
– –
-1,580
Closed -$10.7K
ME
3716
DELISTED
23andMe Holding Co
ME
– –
-175
Closed -$129
HYZN
3717
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
– –
-160
Closed –
KDNY
3718
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
– –
-5
Closed –
ML
3719
DELISTED
MoneyLion Inc.
ML
– –
-4
Closed -$346
LBPS
3720
DELISTED
4D Pharma PLC
LBPS
– –
-5
Closed –
SWI
3721
DELISTED
SolarWinds Corporation Common Stock
SWI
– –
-542
Closed -$9.99K
145 146 147 148
149

Similar funds

HFS
Hantz Financial Services Southfield, Michigan $6.56B AUM 16.11% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
LAM
Lyrical Asset Management New York $6.56B AUM 20.06% 1-Year Est. Return
BF
BOK Financial Tulsa, Oklahoma $6.54B AUM 25.41% 1-Year Est. Return
NMIMC
Northwestern Mutual Investment Management Company Milwaukee, Wisconsin $6.6B AUM 19.75% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Parallel Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, Parallel Advisors held 3,762 positions worth $5B, up 13% from $4.43B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Parallel Advisors's Q2 2025 filing shows 250 new, 1,451 increased, 1,277 reduced and 224 closed positions. Its largest new stake was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M. The largest sale was Corcept Therapeutics, an estimated $7.34M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

  • Parallel Advisors's largest Q2 2025 buy was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M.
  • Parallel Advisors added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $18.4M increase.
  • Parallel Advisors's biggest Q2 2025 reduction was Corcept Therapeutics, cutting an estimated $7.34M.
  • Parallel Advisors fully exited Discover Financial Services in Q2 2025, selling an estimated $1.22M.
  • Parallel Advisors's ten largest holdings make up 39% of its $5B portfolio in Q2 2025.
  • Parallel Advisors opened 250 new positions and closed 224 in Q2 2025.
  • Parallel Advisors's portfolio value rose 13% quarter-over-quarter to $5B.

Based on Parallel Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.